AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-23.2%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.01B
AUM Growth
+$2.01B
(-30%)
Cap. Flow
+$140M
Cap. Flow
% of AUM
6.96%
Top 10 Holdings %
Top 10 Hldgs %
70.26%
Holding
110
New
9
Increased
21
Reduced
12
Closed
14
Top Buys
| 1 |
Moderna
MRNA
|
$80.3M |
| 2 |
Alibaba
BABA
|
$47.6M |
| 3 |
NIO
NIO
|
$26.1M |
| 4 |
Allogene Therapeutics
ALLO
|
$10.8M |
| 5 |
ARRY
Array Biopharma Inc
ARRY
|
$8.55M |
Top Sells
| 1 |
TSRO
TESARO, Inc.
TSRO
|
$31.2M |
| 2 |
Amicus Therapeutics
FOLD
|
$9.58M |
| 3 |
AnaptysBio
ANAB
|
$9.57M |
| 4 |
ZGNX
Zogenix, Inc.
ZGNX
|
$7.29M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$7.29M |
Sector Composition
| 1 | Healthcare | 65.65% |
| 2 | Consumer Discretionary | 33.07% |
| 3 | Real Estate | 0.37% |
| 4 | Communication Services | 0.16% |
| 5 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Wynn Resorts
WYNN
$13.2B
| – | – | 0 | – | – |
|
102
SPDR S&P Biotech ETF
XBI
$5.07B
| – | – | 0 | – | – |
|
103
Xenon Pharmaceuticals
XENE
$2.98B
| – | – | -250,000 | Closed | -$3.3M |
|
|
ATYR
104
aTyr Pharma
ATYR
$527M
| – | – | -500,000 | Closed | -$406K |
|
|
CLVS
105
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – | 0 | – | – |
|
|
HSTO
106
DELISTED
Histogen Inc. Common Stock
HSTO
| – | – | -500,000 | Closed | -$2.9M |
|
|
LOGM
107
DELISTED
LogMein, Inc.
LOGM
| – | – | -65,000 | Closed | -$5.79M |
|
|
TSRO
108
DELISTED
TESARO, Inc.
TSRO
| – | – | -800,000 | Closed | -$31.2M |
|
|
CELG
109
DELISTED
Celgene Corp
CELG
| – | – | 0 | – | – |
|
|
LJPC
110
DELISTED
La Jolla Pharmaceutical Company
LJPC
| – | – | -200,000 | Closed | -$4.03M |
|